Generation in Medical Technology
Navigation Links
Generation in Medical Technology
... of hepatitis C (HCV). PSI-7851 is a second generation nucleotide polymerase inhibitor of HCV.
... and safety data with PSI-7851, our second generation nucleotide analog," said Michelle Berrey, MD, ... 15-fold more potent than Pharmasset's first generation nucleoside polymerase inhibitor, RG7128 (formerly ...
... today the first complete prototype of their next generation LifeShirt for the remote monitoring of patients' ... realization of telemedicine. The next generation LifeShirt incorporates cutting-edge sensor ... intent is to address these needs with the next generation LifeShirt and help make the full promise of RPM a ...
... Forum's commitment to developing a new generation of tools for physicians to learn from peer ... a complementary, accelerated path to knowledge generation and dissemination. "The end goal of this ... ( www.ICSciences.com ). The EVF NGHI (next generation health Internet) community comes together to ...
... important new technology is that it allows the generation of both knock-out rat models, in which the effect of gene deletion is studied, as well as the generation of knock-in models, which involves the insertion ... "This remarkable breakthrough will enable the generation of transgenic rat models for drug discovery in a ...
... a first-in-human micro-dosing study of our second generation NNRTI, RDEA427, and selected it as a ... a first-in-human micro-dosing study of our second generation MEK inhibitor, RDEA436, and selected it as a ... favorable resistance profiles for our next generation NNRTI family of compounds against HIV at the ...
... nucleases (ZFNs(TM)) in a new approach for rapid generation of "knock-out" cell lines, important tools in ... advance in the specificity and efficiency of the generation of cell lines in which an individual gene ... vice president of research. "The generation of knockouts in basic research and industrial ...
... to advance our development of picoplatin, a new generation chemotherapy agent with the potential to become a ... . About Picoplatin Picoplatin is a new generation platinum chemotherapy agent with the potential to ... lead platform product candidate, is a new generation platinum therapy with an improved safety profile. ...
... in stem cells potentially enabling the efficient generation of stem cell lines for use as models of human ... for drug testing. In addition to its use in the generation of valuable research reagents, the technology has ... has revolutionized biology and enabled the generation of mouse cell-lines and transgenic mouse models ...
... announced results from a Phase 1 cardiac safety study of picoplatin, a new generation platinum-based chemotherapy agent and the Company's lead product ... later this year. About Picoplatin Picoplatin is a new generation platinum-based chemotherapy agent that is in clinical development for ...
... be developed for rheumatoid arthritis as well." Thiarabine is a next generation nucleoside analogue that Access has licensed from Southern Research. It ... factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has demonstrated both pre-clinical and clinical ...
... with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein ... obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ...
... Second generation Oxazolidinone Demonstrates Safety and Efficacy with Once-Daily, 200 ... pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about ...
... Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious ... recently commenced a Phase III study in metastatic melanoma following the generation of an unprecedented number of durable complete remissions in a Phase II ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rPA anthrax vaccine Valortim(R) - a fully human monoclonal ...
... rates during DuraHeart support were acceptable in comparison to first generation pulsatile and second generation axial flow LVADs. The event rate of bleeding requiring surgery (0.22 per ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about ...
... changes in certain cells. Continued advances and cost efficiencies of next generation DNA sequencing technologies are enabling this more precise and detailed ... in cancer. The team concluded that transcriptome sequencing with next generation sequencing technologies such as the 454 Life Sciences platform is very ...
... 180 Patient Trial of 2nd generation Oxazolidinone Enrolls in Four Months SAN DIEGO, Jan. 26 /PRNewswire/ ... pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against ...
... for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government Services Canada, on behalf ... 25 % of the population. IMVAMUNE(R), Bavarian Nordic's new, third generation smallpox vaccine, offers a number of unique advantages compared to the old ...
... the pathway for the abnormal heart rhythm. The new study involves second generation software (Gen II) that uses a catheter believed to result in the formation ... temperature at the catheter's tip, overheating may occur, resulting in the generation of a less effective lesion. "While many studies involve less complex ...
... lead product development programs include: -- SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rPA anthrax vaccine -- Valortim(R) -- a fully human monoclonal antibody ...
... Libraries Program (MLP) is a full-scale production program emphasizing the generation of high quality probes and biological-chemical data for high-value ... abilities that will enable screening of diverse types of assays and generation of chemical probes to address a wide range of biological opportunities. ...
... today the first complete prototype of their next generation LifeShirt for the remote monitoring of patients' ... realization of telemedicine. The next generation LifeShirt incorporates cutting-edge sensor ... intent is to address these needs with the next generation LifeShirt and help make the full promise of RPM a ...
... Forum's commitment to developing a new generation of tools for physicians to learn from peer ... a complementary, accelerated path to knowledge generation and dissemination. "The end goal of this ... ( www.ICSciences.com ). The EVF NGHI (next generation health Internet) community comes together to ...
PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
... plans for licensure of SparVax(TM), a next generation recombinant protective antigen anthrax vaccine. ... to develop and procure 25 million doses of a next generation rPA anthrax vaccine for the country's civilian ... the advanced development and procurement of next generation rPA anthrax vaccines." About SparVax(TM) ...Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
... in healthy volunteers with PSI-7851, a second generation nucleotide analog polymerase inhibitor of ... Pharmasset. PSI-7851 is a wholly owned, second generation nucleotide analog that was discovered by ... than the active metabolite of Pharmasset's first generation nucleoside polymerase inhibitor, R7128. In vitro ...Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
... our technology platform, which is unique in its generation of novel, highly differentiated therapies and ... establishing the utility of ZFNs in the generation of transgenic animals and the potential ... ZFN technology as a new approach for rapid generation of "knock-out" cell lines (Santiago et al., 2008, ...... important new technology is that it allows the generation of both knock-out rat models, in which the effect of gene deletion is studied, as well as the generation of knock-in models, which involves the insertion ... "This remarkable breakthrough will enable the generation of transgenic rat models for drug discovery in a ...
... a first-in-human micro-dosing study of our second generation NNRTI, RDEA427, and selected it as a ... a first-in-human micro-dosing study of our second generation MEK inhibitor, RDEA436, and selected it as a ... favorable resistance profiles for our next generation NNRTI family of compounds against HIV at the ...
... nucleases (ZFNs(TM)) in a new approach for rapid generation of "knock-out" cell lines, important tools in ... advance in the specificity and efficiency of the generation of cell lines in which an individual gene ... vice president of research. "The generation of knockouts in basic research and industrial ...
... to advance our development of picoplatin, a new generation chemotherapy agent with the potential to become a ... . About Picoplatin Picoplatin is a new generation platinum chemotherapy agent with the potential to ... lead platform product candidate, is a new generation platinum therapy with an improved safety profile. ...
... in stem cells potentially enabling the efficient generation of stem cell lines for use as models of human ... for drug testing. In addition to its use in the generation of valuable research reagents, the technology has ... has revolutionized biology and enabled the generation of mouse cell-lines and transgenic mouse models ...
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
... modified animal models of human disease. ZFN technology will make the generation of such animals faster and will create new opportunities in species other ... transgenic rats using DNA or lentiviral vector microinjection. The generation of transgenic rats also is open to the scientific community through an ...... announced results from a Phase 1 cardiac safety study of picoplatin, a new generation platinum-based chemotherapy agent and the Company's lead product ... later this year. About Picoplatin Picoplatin is a new generation platinum-based chemotherapy agent that is in clinical development for ...
... be developed for rheumatoid arthritis as well." Thiarabine is a next generation nucleoside analogue that Access has licensed from Southern Research. It ... factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has demonstrated both pre-clinical and clinical ...
... with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein ... obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ...
... Second generation Oxazolidinone Demonstrates Safety and Efficacy with Once-Daily, 200 ... pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against ...
Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
... for download from the journal's website. "Thiarabine is a next generation nucleoside analogue, licensed by Access from Southern Research Institute ... factor and is targeted to breast cancer. Thiarabine is a new generation nucleoside analog which has demonstrated both pre-clinical and clinical ...... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about ...
First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology
... it can be grown on marginal, non-food producing lands; has a very short generation time; can be productive for 30 to 40 years; and its seed oil and biomass ... of the genome, using both traditional Sanger sequencing and next generation sequencing, has revealed that the jatropha genome is approximately 400 ...... Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious ... recently commenced a Phase III study in metastatic melanoma following the generation of an unprecedented number of durable complete remissions in a Phase II ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rPA anthrax vaccine Valortim(R) - a fully human monoclonal ...
Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
... Study for the treatment of lumbar spinal stenosis utilizes the second generation design technology from Facet Solutions, Inc. This technology enables the ... stability to the lumbar spine. Average implantation times with the second generation design are equivalent to implantation times for standard postero-lateral ...Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
... trial at the upcoming EASL meeting. Pharmasset's unpartnered second generation HCV nucleoside, PSI-7851, is progressing well in a phase I trial and we ... has completed a Phase 2 clinical trial. PSI-7851, an unpartnered second generation HCV nucleotide analogue recently entered phase 1 studies. Pegasys(R) ...AACR Data Highlights InNexus Preclinical Antibody Candidate
... ), a drug development company commercializing the next generation of monoclonal antibodies based on its technology, Dynamic Cross Linking ... InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the ...... rates during DuraHeart support were acceptable in comparison to first generation pulsatile and second generation axial flow LVADs. The event rate of bleeding requiring surgery (0.22 per ...
... development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about ...
DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
... platform, this will open up a broad range of opportunities for next generation drug delivery. DSM's activities in this field are a perfect illustration ... technology for the delivery of biologics and drugs is based on a next generation set of polymers exclusively licensed from Cornell University . Generated ...... changes in certain cells. Continued advances and cost efficiencies of next generation DNA sequencing technologies are enabling this more precise and detailed ... in cancer. The team concluded that transcriptome sequencing with next generation sequencing technologies such as the 454 Life Sciences platform is very ...
... 180 Patient Trial of 2nd generation Oxazolidinone Enrolls in Four Months SAN DIEGO, Jan. 26 /PRNewswire/ ... pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against ...
Gene Therapy Corrects Sickle Cell Disease in Laboratory Study
... altered blood-forming cells from the original treated mice into a second generation of sickle cell mice to show that the gamma-globin gene had incorporated ... blood-forming cells. Five months after that transplantation, the second generation of mice also showed production of fetal hemoglobin and correction of their ...... for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government Services Canada, on behalf ... 25 % of the population. IMVAMUNE(R), Bavarian Nordic's new, third generation smallpox vaccine, offers a number of unique advantages compared to the old ...
PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
... lead product development programs include: -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rPA anthrax vaccine -- Valortim(R) - a fully human monoclonal antibody ...... the pathway for the abnormal heart rhythm. The new study involves second generation software (Gen II) that uses a catheter believed to result in the formation ... temperature at the catheter's tip, overheating may occur, resulting in the generation of a less effective lesion. "While many studies involve less complex ...
... lead product development programs include: -- SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rPA anthrax vaccine -- Valortim(R) -- a fully human monoclonal antibody ...
... Libraries Program (MLP) is a full-scale production program emphasizing the generation of high quality probes and biological-chemical data for high-value ... abilities that will enable screening of diverse types of assays and generation of chemical probes to address a wide range of biological opportunities. ...
febit and TGen Collaborate to Study New DNA Capture Method
... conversation on the future direction of genomic research centers on next generation sequencing," said Matthew Huentelman, Ph.D., TGen associate investigator ... for TGen researchers to make a difference in research utilizing next generation sequencing." TGen has been a user of the Geniom One device for the ...First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
... readily available for the increasing need of heart failure patients. Third generation systems are anticipated to demonstrate improved outcomes and long term reliability. DuraHeart is the most advanced third generation centrifugal pump by virtue of the magnetically levitated impeller, ...New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
... First Patients Treated Using Next generation CyberKnife System at Oklahoma CyberKnife Center ... Oklahoma CyberKnife, LLC purchased its CyberKnife System with all the next generation upgrades included, those same upgrades were made available to existing ...Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
... in a fifth phase 1 and 2 clinical oncology study of AEG35156, a second generation antisense therapeutic targeting XIAP, a key member of the Inhibitor of ... disable their normal response to apoptotic triggers. AEG35156, a second generation antisense which targets XIAP, is designed to lower the apoptotic threshold ...Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
... its intranasal vaccine deltaFLU against pandemic influenza. This novel generation of a live-attenuated vaccine based on the deletion of the NS1 gene has ... has optimized the method of reverse genetics, which permits the generation of a vaccine against any potential influenza virus within a very short ...Other ContentstendernesstendernessovariesovariesovariesovariesivypoisonpoisonpoisonpoisoningpoisoningpoisoningpoisoningpolvaccinesvaccinesvaccinesvaccinesvaccinespoliopoliopoliopolioOther TagsPACHYReposableBTTCannulaeconductive
(Date:11/23/2009)...trong evidence that the "synergistic" effect of ea...pollution and indoor endotoxin causes more harm to...lone. , Environmental health scientists at the... have shown that children exposed to both high lev...xin during early life are six times more likely to...
(Date:11/23/2009)...servation Society says that western lowland gorill...opart of the "mother lode" of more than 125,000 go...ly threatened by growing humans activity in the re...wamp forests adjacent to the southwest border of L...rmed that high densities of the great apes still e...
(Date:11/23/2009)...cine available for the H1N1 virus has been sent to...he vaccination marks the first time vaccine has be...c flu., Iowa State University,s Hank Harris, pro...is summer and has been shipping preventive doses t... several weeks., The latest vaccines were shippe...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2This October Lady Foot Locker Is Fashioned for a Cause 58925 1This October Lady Foot Locker Is Fashioned for a Cause 58925 2Doctors Don 26apos 3Bt Always Know Best 3A The Rise of e Patients Offers a New Prescription for Resounding Health 58922 1Doctors Don 26apos 3Bt Always Know Best 3A The Rise of e Patients Offers a New Prescription for Resounding Health 58922 2Doctors Don 26apos 3Bt Always Know Best 3A The Rise of e Patients Offers a New Prescription for Resounding Health 58922 3KTA Capital Advises SpringTree Global Investors on an AU 247 2 Million Investment in HealthLinx Ltd 58917 1KTA Capital Advises SpringTree Global Investors on an AU 247 2 Million Investment in HealthLinx Ltd 58917 2(Date:11/27/2009)...ch firm Replikins Ltd. today issued its latest bio... It shows that the lethality of the virus has drop...us,s current outbreak in the spring of 2009 to res...1). The H1N1 infectivity count, however, remains i...) November 27, 2009 -- Biotech firm Replikins Ltd....
(Date:11/27/2009)...v. 27 Preventing diseas...rtunately every year, new vaccines are being added...nes boost immunity for the same period of time? An...ded to keep immunity strong? ,, In this month...n Academy of Pediatrics, Michael Pichichero MD, Di...
(Date:11/27/2009)...are Holdings has announced that it has become a na... the largest nonprofit organizations dedicated to ... Delray Beach, FL (Vocus) ...B: XCHO), a company specializing in the marketing ...ducts, has announced today that is has become a na...
(Date:11/27/2009)...TTLE, Nov. 27 Allrecipes.com , ...nksgiving traffic numbers, with more than 2.8 mill...g a clear picture of what was served on the bigges...ng meal in 2009 weighed in at 2,225 calories per s...t. According to the Allrecipes site, Sweet Potato...
(Date:11/27/2009)...alist manufacturers who use medical load cells at ... dollars by bringing in technology partner Flintec...f pro-active medical manufacturers are calling in ...their projects, ensuring that progress will not be...tially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4[0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased[0] Why Some Vaccines May Require A Booster[0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [0] It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories[0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells
oprifoconpaflufoconPACHYReposableBTTReducersPowerShieldCannulaeRPFObturatorsConverterlessPneumoperitoneumconductiveBladed
Other Tagsvaccinations 2vaccinations 3vaccinations 4vaccinations 5mapped 2classification 2tan 2brain 2brain 3brain 4brain 5brain 6brain 7brain 8brain 9brain 10act 2act 3act 4act 5act 6act 7act 8act 9act 10drug 2drug 3drug 4drug 5drug 6drug 7drug 8drug 9drug 10controversial 2controversial 3mutation 2mutation 3mutation 4mutation 5mutation 6mutation 7mutation 8mutation 9mutation 10immune 2immune 3immune 4immune 5immune 6immune 7immune 8immune 9immune 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |